According to foreign news reports，China starts to expand the scope of the "National Basic Medical Insurance Drug Catalog"，This will benefit Western pharmacies such as Astrazeneca and Sanofi-Aventis。

This is the first time China has updated the "National Basic Medical Insurance Drug Catalog" since 2004，Many drugs from Western Pharmaceutical Factory are included in My stake betting appit，stake online sports bettingAmong them, Crestor includes Astraikon's cholesterol drug、Angina pectoris drug nexium，and Sanofer's anticoagulant drug Plavix et al.。

At present, Chinese drug expenditures are less than 5%of the GDP (GDP)，But it is expected to increase by 18%per year，Therefore, in the next three or five years, it will be a huge benefits for Western pharmaceutical vendors。Due to the stagnation of the Western market，Large pharmacies will increase their attention to emerging markets，For example, China、India、Brazil、Russia and Türkiye。